TransMedics Group, Inc.
TMDX
$117.38
$2.201.91%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 186.26% | 110.56% | 70.11% | 116.58% | 1,318.18% |
| Total Depreciation and Amortization | 46.36% | 42.65% | 57.56% | 173.48% | 230.39% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.87% | 19.16% | 108.09% | -72.94% | 54.45% |
| Change in Net Operating Assets | 22,603.39% | -58.03% | -4.91% | 27.60% | 101.49% |
| Cash from Operations | 256.21% | 16.89% | 136.79% | 199.84% | 543.18% |
| Capital Expenditure | 61.81% | 38.79% | 67.46% | 55.25% | -1,621.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 102.96% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 61.81% | 38.79% | 67.46% | 68.12% | -1,621.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -33.38% | -4.93% | 28.35% | 416.22% | 1,409.36% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -33.38% | -4.93% | 28.35% | 416.22% | -97.30% |
| Foreign Exchange rate Adjustments | 1,404.84% | 306.94% | -335.27% | 318.08% | -1,340.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 621.49% | 40.56% | 120.30% | 78.98% | -96.76% |